238 related articles for article (PubMed ID: 8455096)
81. Rocky Flats Beryllium Health Surveillance.
Stange AW; Furman FJ; Hilmas DE
Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):981-6. PubMed ID: 8933045
[TBL] [Abstract][Full Text] [Related]
82. Identification of an abnormal beryllium lymphocyte proliferation test.
Frome EL; Newman LS; Cragle DL; Colyer SP; Wambach PF
Toxicology; 2003 Feb; 183(1-3):39-56. PubMed ID: 12504341
[TBL] [Abstract][Full Text] [Related]
83. Possible health risks from low level exposure to beryllium.
Stange AW; Hilmas DE; Furman FJ
Toxicology; 1996 Jul; 111(1-3):213-24. PubMed ID: 8711738
[TBL] [Abstract][Full Text] [Related]
84. [Normal blood lymphocyte blast transformation in berylliosis and silicosis patients].
Shpakova AP; Sokolov VV
Gig Tr Prof Zabol; 1976 Aug; (8):19-22. PubMed ID: 1010369
[No Abstract] [Full Text] [Related]
85. Development of beryllium lymphocyte transformation tests in chronic beryllium disease.
Williams WR; Williams WJ
Int Arch Allergy Appl Immunol; 1982; 67(2):175-80. PubMed ID: 7056594
[TBL] [Abstract][Full Text] [Related]
86. Chronic beryllium disease and sensitization at a beryllium processing facility.
Rosenman K; Hertzberg V; Rice C; Reilly MJ; Aronchick J; Parker JE; Regovich J; Rossman M
Environ Health Perspect; 2005 Oct; 113(10):1366-72. PubMed ID: 16203248
[TBL] [Abstract][Full Text] [Related]
87. [Health surveillance for workers exposed to beryllium and diagnostic procedures in beryllium-associated diseases].
Euler U; Dahmann D; Follmann M; Gaede KI; Gäßler A; Groneberg D; Heger M; Krutz K; Latza U; Lelgemann M; Letzel S; Merget R; Müller-Quernheim J; Nauert T; Seidler A;
Dtsch Med Wochenschr; 2013 Mar; 138(10):488-92. PubMed ID: 23444026
[No Abstract] [Full Text] [Related]
88. The beryllium bronchoalveolar lavage lymphocyte proliferation test: indicator of beryllium sensitization, inflammation or both?
Heldt GH; Deubner DC
Inhal Toxicol; 2015; 27(5):262-71. PubMed ID: 25942054
[TBL] [Abstract][Full Text] [Related]
89. Reversible beryllium sensitization in a prospective study of beryllium workers.
Rom WN; Lockey JE; Bang KM; Dewitt C; Johns RE
Arch Environ Health; 1983; 38(5):302-7. PubMed ID: 6651355
[TBL] [Abstract][Full Text] [Related]
90. Screening for chronic beryllium disease using beryllium specific lymphocyte proliferation testing.
Markham TN
Int Arch Occup Environ Health; 1996; 68(6):405-7. PubMed ID: 8891776
[No Abstract] [Full Text] [Related]
91. Immune mechanisms in beryllium lung disease.
Deodhar SD; Barna BP
Cleve Clin J Med; 1991; 58(2):157-60. PubMed ID: 2025920
[TBL] [Abstract][Full Text] [Related]
92. Interstitial pneumonia in a glassblower: think to chronic beryllium disease!
Jamoussi A; Merhabene T; Mlika M; Neji H; El Mezni F; Khelil JB; Besbes M
Pan Afr Med J; 2018; 31():95. PubMed ID: 31011396
[TBL] [Abstract][Full Text] [Related]
93. Role of in vitro and in vivo tests of hypersensitivity in beryllium workers.
Price CD; Williams WJ; Pugh A; Joynson DH
J Clin Pathol; 1977 Jan; 30(1):24-28. PubMed ID: 320228
[TBL] [Abstract][Full Text] [Related]
94. Comparison of lymphocyte transformation and macrophage migration inhibition tests in the detection of beryllium hypersensitivity.
Williams WR; Williams WJ
J Clin Pathol; 1982 Jun; 35(6):684-7. PubMed ID: 7085919
[TBL] [Abstract][Full Text] [Related]
95. Application of beryllium antibodies in risk assessment and health surveillance: two case studies.
Clarke SM; Thurlow SM; Hilmas DE
Toxicol Ind Health; 1995; 11(4):399-411. PubMed ID: 8748421
[TBL] [Abstract][Full Text] [Related]
96. Beryllium Biobank 3: considerations for improving chronic beryllium disease screening.
Harber P; Su J
J Occup Environ Med; 2014 Aug; 56(8):861-6. PubMed ID: 25099414
[TBL] [Abstract][Full Text] [Related]
97. Blood testing for chronic beryllium disease.
Kreiss K; Newman LS; Mroz M
J Occup Med; 1991 Nov; 33(11):1188-9. PubMed ID: 1765863
[No Abstract] [Full Text] [Related]
98. Lymphocyte transformation test in a group of foundry workers exposed to beryllium and non-exposed controls.
Bargon J; Kronenberger H; Bergmann L; Buhl R; Meier-Sydow J; Mitrou P
Eur J Respir Dis Suppl; 1986; 146():211-5. PubMed ID: 3465548
[No Abstract] [Full Text] [Related]
99. Secondary ion mass spectroscopy demonstrates retention of beryllium in chronic beryllium disease granulomas.
Sawyer RT; Abraham JL; Daniloff E; Newman LS
J Occup Environ Med; 2005 Dec; 47(12):1218-26. PubMed ID: 16340702
[TBL] [Abstract][Full Text] [Related]
100. [Delayed-type immune response by means of skin test with beryllium chloride and sulfate in workers exposed to beryllium and its compounds].
Cianciara M
Pol Tyg Lek; 1976 Feb; 31(8):305-6. PubMed ID: 1257145
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
